Member Article

Durham pharma plc lands extended five year contract

Durham-based pharmaceutical manufacturer Quantum Pharma Plc has announced that Quantum Pharmaceutical Limited, the largest business unit in the group’s specials division, has signed a new five-year contract extension with AAH Pharmaceuticals Limited.

AAH is a wholesaler and distributor of pharmaceutical and healthcare products and services to pharmacy, hospitals and dispensing doctors. AAH is a division of Celesio UK which owns Lloyds Pharmacy and has a growing presence in the UK retail pharmacy sector.

Quantum, which manufactures and supplies unlicensed medicines and special obtain products, has enjoyed a relationship with AAH since 2008. Under the terms of the new contract extension, Quantum will continue to be the exclusive supplier of specials and special obtains to AAH for the next five years, together with the provisions of certain order handling, procurement and distribution services in connection with such supply.

Andrew Scaife, Chief Executive of Quantum Pharma Plc, commented: “We are delighted to have signed this contract extension with AAH, a long term partner with whom Quantum has built a strong relationship.

“Not only is this partnership with AAH important for the Group financially, such strategic relationships with our Specials division also provide a further route to market for our licensed products and medical devices from our Niche Pharmaceutical division as well as potential partners for Biodose Connect® in our Medication Adherence division.

“We believe that no other specials supplier in the UK can rival what Quantum offers in relation to breadth of manufactured range, obtains procurement, capacity and delivery times; all backed by high levels of service and support.”